We are live on ! Find out more
SG Americas Securities

SG Americas Securities Portfolio holdings

AUM $92.9B
1-Year Est. Return 36.98%
This Fund
S&P 500
This Quarter Est. Return
+10.29%
1 Year Est. Return
+36.98%
3 Year Est. Return
+96.33%
5 Year Est. Return
+110.18%
10 Year Est. Return
+436.29%
AUM
$24.4B
AUM Growth
-$3.21B
Cap. Flow
-$7.81B
Cap. Flow %
-32.05%
Top 10 Hldgs %
57.2%
Holding
3,755
New
362
Increased
1,347
Reduced
1,159
Closed
663

Sector Composition

Rank Sector Weight
1 Technology 39.9%
2 Communication Services 23.12%
3 Industrials 4.7%
4 Consumer Discretionary 4.48%
5 Healthcare 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GTM
1526
ZoomInfo Technologies
GTM
$1.05B
$380K ﹤0.01%
36,190
-7,798
-18% -$83.4K
SCS
1527
DELISTED
Steelcase
SCS
$379K ﹤0.01%
+32,052
New +$412K
TMDX icon
1528
Transmedics
TMDX
$2.82B
$379K ﹤0.01%
6,083
-2,276
-27% -$212K
OEC icon
1529
Orion
OEC
$385M
$378K ﹤0.01%
23,911
+3,646
+18% +$61.6K
WFRD icon
1530
Weatherford International
WFRD
$6.33B
$378K ﹤0.01%
5,281
-551
-9% -$45.2K
AHCO icon
1531
AdaptHealth
AHCO
$1.47B
$375K ﹤0.01%
39,346
-13,249
-25% -$134K
NTGR icon
1532
NETGEAR
NTGR
$648M
$375K ﹤0.01%
+13,461
New +$316K
VRTS icon
1533
Virtus Investment Partners
VRTS
$1.13B
$375K ﹤0.01%
+1,698
New +$387K
TBBB icon
1534
BBB Foods
TBBB
$5.17B
$375K ﹤0.01%
+13,276
New +$414K
AMN icon
1535
AMN Healthcare
AMN
$1.28B
$374K ﹤0.01%
15,647
-3,264
-17% -$104K
AVXL icon
1536
Anavex Life Sciences
AVXL
$273M
$374K ﹤0.01%
34,844
+7,138
+26% +$54.9K
ELVN icon
1537
Enliven Therapeutics
ELVN
$4.15B
$374K ﹤0.01%
16,629
+6,616
+66% +$172K
PCRX icon
1538
Pacira BioSciences
PCRX
$1.06B
$374K ﹤0.01%
19,847
-5,407
-21% -$94.9K
RYAM icon
1539
Rayonier Advanced Materials
RYAM
$608M
$374K ﹤0.01%
45,367
+11,384
+33% +$95.8K
UGP icon
1540
Ultrapar
UGP
$6.94B
$374K ﹤0.01%
+142,151
New +$471K
BPMC
1541
DELISTED
Blueprint Medicines
BPMC
$373K ﹤0.01%
4,277
+1,756
+70% +$161K
GSK icon
1542
GSK
GSK
$103B
$372K ﹤0.01%
10,991
-7,782
-41% -$280K
OFIX icon
1543
Orthofix Medical
OFIX
$496M
$372K ﹤0.01%
21,279
+4,162
+24% +$72.4K
RTX icon
1544
RTX Corp
RTX
$292B
$372K ﹤0.01%
3,215
-111,395
-97% -$13.5M
TEM
1545
Tempus AI
TEM
$8.31B
$372K ﹤0.01%
+11,032
New +$546K
AMSF icon
1546
AMERISAFE
AMSF
$564M
$371K ﹤0.01%
7,195
-584
-8% -$31.6K
ICHR icon
1547
Ichor Holdings
ICHR
$2.8B
$371K ﹤0.01%
11,503
-3,937
-25% -$122K
ATSG
1548
DELISTED
Air Transport Services Group
ATSG
$371K ﹤0.01%
16,863
+3,597
+27% +$71.2K
KRNY icon
1549
Kearny Financial
KRNY
$610M
$370K ﹤0.01%
52,275
+11,373
+28% +$85.5K
NE.WS.A icon
1550
Noble Corporation PLC Tranche 2 Warrants
NE.WS.A
$370K ﹤0.01%
34,812

Similar funds

SG Americas Securities's Q4 2024 Portfolio in Review

As of Q4 2024, SG Americas Securities held 3,755 positions worth $24.4B, down 12% from $27.6B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

SG Americas Securities withdrew a net $7.81B in Q4 2024, closing 663 positions and reducing 1,159 holdings. Its most notable exit was Invesco Senior Loan ETF, an estimated $74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 32% a quarter earlier, followed by Communication Services and Industrials.

Against the trend, SG Americas Securities opened a new position in iShares Ethereum Trust ETF worth $49.8M.

  • SG Americas Securities's largest Q4 2024 buy was iShares Ethereum Trust ETF: 1,971,000 shares worth $49.8M.
  • SG Americas Securities added most to Broadcom in Q4 2024, an estimated $912M increase.
  • SG Americas Securities's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.87B.
  • SG Americas Securities fully exited Invesco Senior Loan ETF in Q4 2024, selling an estimated $74M.
  • SG Americas Securities's ten largest holdings make up 57% of its $24.4B portfolio in Q4 2024.
  • SG Americas Securities opened 362 new positions and closed 663 in Q4 2024.
  • SG Americas Securities's portfolio value fell 12% quarter-over-quarter to $24.4B.

Based on SG Americas Securities's 13F filing for Q4 2024, filed 17 Jan 2025.